116 related articles for article (PubMed ID: 33320604)
1. Lipid and Biosurfactant Based Core-Shell-Type Nanocapsules Having High Drug Loading of Paclitaxel for Improved Breast Cancer Therapy.
Katiyar SS; Ghadi R; Kushwah V; Dora CP; Jain S
ACS Biomater Sci Eng; 2020 Dec; 6(12):6760-6769. PubMed ID: 33320604
[TBL] [Abstract][Full Text] [Related]
2. Lipid- and TPGS-Based Core-Shell-Type Nanocapsules Endowed with High Paclitaxel Loading and Enhanced Anticancer Potential.
Katiyar SS; Patil R; Ghadi R; Kuche K; Kushwah V; Dora CP; Jain S
AAPS PharmSciTech; 2022 Aug; 23(7):238. PubMed ID: 36002600
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of cellular uptake and cytotoxicity of paclitaxel loaded lipid nanocapsules in breast cancer cells.
Valsalakumari R; Yadava SK; Szwed M; Pandya AD; Mælandsmo GM; Torgersen ML; Iversen TG; Skotland T; Sandvig K; Giri J
Int J Pharm; 2021 Mar; 597():120217. PubMed ID: 33486035
[TBL] [Abstract][Full Text] [Related]
4. Paclitaxel loaded fibrinogen coated CdTe/ZnTe core shell nanoparticles for targeted imaging and drug delivery to breast cancer cells.
Rejinold NS; Baby T; Nair SV; Jayakumar R
J Biomed Nanotechnol; 2013 Oct; 9(10):1657-71. PubMed ID: 24015495
[TBL] [Abstract][Full Text] [Related]
5. Novel biosurfactant and lipid core-shell type nanocapsular sustained release system for intravenous application of methotrexate.
Katiyar SS; Kushwah V; Dora CP; Jain S
Int J Pharm; 2019 Feb; 557():86-96. PubMed ID: 30584909
[TBL] [Abstract][Full Text] [Related]
6. Sustained release paclitaxel-loaded core-shell-structured solid lipid microparticles for intraperitoneal chemotherapy of ovarian cancer.
Han S; Dwivedi P; Mangrio FA; Dwivedi M; Khatik R; Cohn DE; Si T; Xu RX
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):957-967. PubMed ID: 30892967
[TBL] [Abstract][Full Text] [Related]
7. Lipid and TPGS based novel core-shell type nanocapsular sustained release system of methotrexate for intravenous application.
Katiyar SS; Kushwah V; Dora CP; Jain S
Colloids Surf B Biointerfaces; 2019 Feb; 174():501-510. PubMed ID: 30497012
[TBL] [Abstract][Full Text] [Related]
8. Paclitaxel and Erlotinib-co-loaded Solid Lipid Core Nanocapsules: Assessment of Physicochemical Characteristics and Cytotoxicity in Non-small Cell Lung Cancer.
Gupta B; Poudel BK; Regmi S; Pathak S; Ruttala HB; Gautam M; An GJ; Jeong JH; Choi HG; Yong CS; Kim JO
Pharm Res; 2018 Mar; 35(5):96. PubMed ID: 29536182
[TBL] [Abstract][Full Text] [Related]
9. Exploring the synergistic behavior of paclitaxel and vorinostat upon co-loading in albumin nanoparticles for breast cancer management.
Abhang A; Katari O; Ghadi R; Chaudhari D; Jain S
Drug Deliv Transl Res; 2024 Feb; 14(2):510-523. PubMed ID: 37605040
[TBL] [Abstract][Full Text] [Related]
10. Tumor microenvironment responsive VEGF-antibody functionalized pH sensitive liposomes of docetaxel for augmented breast cancer therapy.
Jain S; Deore SV; Ghadi R; Chaudhari D; Kuche K; Katiyar SS
Mater Sci Eng C Mater Biol Appl; 2021 Feb; 121():111832. PubMed ID: 33579470
[TBL] [Abstract][Full Text] [Related]
11. Core-shell nanocarriers with high paclitaxel loading for passive and active targeting.
Jin Z; Lv Y; Cao H; Yao J; Zhou J; He W; Yin L
Sci Rep; 2016 Jun; 6():27559. PubMed ID: 27278751
[TBL] [Abstract][Full Text] [Related]
12. Lipid nanocapsules co-encapsulating paclitaxel and salinomycin for eradicating breast cancer and cancer stem cells.
Basu SM; Yadava SK; Singh R; Giri J
Colloids Surf B Biointerfaces; 2021 Aug; 204():111775. PubMed ID: 33940518
[TBL] [Abstract][Full Text] [Related]
13. Development of multifunctional lipid nanocapsules for the co-delivery of paclitaxel and CpG-ODN in the treatment of glioblastoma.
Lollo G; Vincent M; Ullio-Gamboa G; Lemaire L; Franconi F; Couez D; Benoit JP
Int J Pharm; 2015 Nov; 495(2):972-80. PubMed ID: 26428632
[TBL] [Abstract][Full Text] [Related]
14. Novel polymer coupled lipid nanoparticle of paclitaxel with synergistic enhanced efficacy against cancer.
Singodia D; Talegaonkar S; Khar RK; Mishra PR
J Biomed Nanotechnol; 2011 Feb; 7(1):125-6. PubMed ID: 21485835
[TBL] [Abstract][Full Text] [Related]
15. Folate-modified lipid-polymer hybrid nanoparticles for targeted paclitaxel delivery.
Zhang L; Zhu D; Dong X; Sun H; Song C; Wang C; Kong D
Int J Nanomedicine; 2015; 10():2101-14. PubMed ID: 25844039
[TBL] [Abstract][Full Text] [Related]
16. Exploring an interesting dual functionality of anacardic acid for efficient paclitaxel delivery in breast cancer therapy.
Rege MD; Ghadi R; Katiyar SS; Kushwah V; Jain S
Nanomedicine (Lond); 2019 Jan; 14(1):57-75. PubMed ID: 30543141
[TBL] [Abstract][Full Text] [Related]
17. TAT Peptide-Conjugated Magnetic PLA-PEG Nanocapsules for the Targeted Delivery of Paclitaxel: In Vitro and Cell Studies.
Koutsiouki K; Angelopoulou A; Ioannou E; Voulgari E; Sergides A; Magoulas GE; Bakandritsos A; Avgoustakis K
AAPS PharmSciTech; 2017 Apr; 18(3):769-781. PubMed ID: 27301873
[TBL] [Abstract][Full Text] [Related]
18. Unfolding the Potency of Adenosine in Targeting Triple Negative Breast Cancer via Paclitaxel-Incorporated pH-Responsive Stealth Liposomes.
Chaudhari D; Katari O; Ghadi R; Kuche K; Date T; Bhargavi N; Jain S
ACS Biomater Sci Eng; 2022 Aug; 8(8):3473-3484. PubMed ID: 35896042
[TBL] [Abstract][Full Text] [Related]
19. Reconstituted high density lipoprotein mediated targeted co-delivery of HZ08 and paclitaxel enhances the efficacy of paclitaxel in multidrug-resistant MCF-7 breast cancer cells.
Zhang F; Wang X; Xu X; Li M; Zhou J; Wang W
Eur J Pharm Sci; 2016 Sep; 92():11-21. PubMed ID: 27343697
[TBL] [Abstract][Full Text] [Related]
20. Effects of PEGylated paclitaxel nanocrystals on breast cancer and its lung metastasis.
Zhang H; Hu H; Zhang H; Dai W; Wang X; Wang X; Zhang Q
Nanoscale; 2015 Jun; 7(24):10790-800. PubMed ID: 26038337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
